<p class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Pricing information, etc., required by regulations</p><ul class="Section ProvisionList" id="413386"><li><p class="Subsection" id="413388"><strong><a class="sectionLabel" id="s-80"><span class="sectionLabel">80</span></a></strong> <span class="lawlabel">(1)</span> A patentee of an invention pertaining to a medicine shall, as required by and in accordance with the regulations, provide the Board with such information and documents as the regulations may specify respecting</p><ul class="ProvisionList"><li><p class="Paragraph" id="413389"><span class="lawlabel">(a)</span> the identity of the medicine;</p></li><li><p class="Paragraph" id="413390"><span class="lawlabel">(b)</span> the price at which the medicine is being or has been sold in any market in Canada and elsewhere;</p></li><li><p class="Paragraph" id="413391"><span class="lawlabel">(c)</span> the costs of making and marketing the medicine, where that information is available to the patentee in Canada or is within the knowledge or control of the patentee;</p></li><li><p class="Paragraph" id="413392"><span class="lawlabel">(d)</span> the factors referred to in section 85; and</p></li><li><p class="Paragraph" id="413393"><span class="lawlabel">(e)</span> any other related matters.</p></li></ul></li><li><p class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Idem</p><p class="Subsection" id="413394"><span class="lawlabel">(2)</span> Subject to subsection (3), a person who is a former patentee of an invention pertaining to a medicine shall, as required by and in accordance with the regulations, provide the Board with such information and documents as the regulations may specify respecting</p><ul class="ProvisionList"><li><p class="Paragraph" id="413396"><span class="lawlabel">(a)</span> the identity of the medicine;</p></li><li><p class="Paragraph" id="413397"><span class="lawlabel">(b)</span> the price at which the medicine was sold in any market in Canada and elsewhere during the period in which the person was a patentee of the invention;</p></li><li><p class="Paragraph" id="413398"><span class="lawlabel">(c)</span> the costs of making and marketing the medicine produced during that period, whether incurred before or after the patent was issued, where that information is available to the person in Canada or is within the knowledge or control of the person;</p></li><li><p class="Paragraph" id="413399"><span class="lawlabel">(d)</span> the factors referred to in section 85; and</p></li><li><p class="Paragraph" id="413400"><span class="lawlabel">(e)</span> any other related matters.</p></li></ul></li><li><p class="MarginalNote"><span class="wb-invisible">Marginal note:</span>Limitation</p><p class="Subsection" id="413401"><span class="lawlabel">(3)</span> Subsection (2) does not apply to a person who has not been entitled to the benefit of the patent or to exercise any rights in relation to the patent for a period of three or more years.</p></li></ul><div class="HistoricalNote"><ul class="HistoricalNote"><li class="HistoricalNoteSubItem">1993, c. 2, s. 7</li></ul></div>